Barcoded Cancer Cell Tracking for Metastasis Mapping
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for characterizing the metastatic potential of cancer cell lines are limited by their inability to tractably assess complex in vivo behaviors at scale, relying on rudimentary metrics and small experimental models, making it difficult to extrapolate findings to genetically diverse human tumors.
Innovation Solution
A method involving the systemic delivery of cancer cells to a non-human subject, each equipped with a vector encoding a barcode, a bioluminescent marker for imaging, and a marker for cell selection, allowing for the characterization of metastatic potential by tracking the cells' location and proliferation within the body, generating a metastasis map that includes genomic, transcriptomic, and proteomic data.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If in vivo testing of each cell line is performed one-by-one, then comprehensive metastatic characterization is achieved, but labor intensity and difficulty in controlling variability increase significantly
Solution Approach 1:
The patent segments the metastatic characterization process by introducing unique barcodes to individual cell lines, allowing parallel testing of multiple cell lines through pooled transplantation. This enables high-throughput screening while maintaining the ability to track and analyze each cell line's metastatic behavior separately through barcode identification.
Solution Approach 2:
The patent creates genetic copies (barcodes) of cell line identities that can be tracked independently. These barcode sequences serve as molecular fingerprints that allow researchers to identify and quantify each cell line's contribution to metastatic colonies without physically separating the cells during the experiment.
2Reliability
If a small number of experimental models are used, then experimental control is improved, but the ability to extrapolate findings to genetically diverse human tumors is limited
Solution Approach 1:
The patent creates a universal barcoding system that can be applied across diverse human cancer cell lines from multiple tissue types. The standardized barcode integration method and pooled transplantation approach provide a multi-functional platform that maintains experimental control while enabling the study of genetically diverse tumors in a unified system.
Solution Approach 2:
The patent changes the experimental parameter from testing individual cell lines separately to testing pooled cell lines with unique barcodes. This parameter change allows simultaneous evaluation of multiple cell lines under identical experimental conditions, improving both control and diversity.
3Reliability
If barcoded cells are transplanted into multiple mice, then statistical power is improved, but the complexity of tracking and analyzing results increases
Solution Approach 1:
The patent replaces manual tracking methods with molecular identification using DNA barcodes. Instead of physically tracking individual cells or colonies, researchers can extract DNA from metastatic tissues and identify cell line origins through sequence analysis, dramatically simplifying data tracking while enabling analysis of multiple mice and cell lines.
Solution Approach 2:
The barcode sequence serves as an intermediary between the physical cell and its identity. This molecular mediator allows indirect identification of cell line origins in metastatic colonies, eliminating the need for direct observation or physical tracking of individual cells throughout the experimental process.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables efficient and large-scale characterization of metastatic potential, providing a comprehensive metastasis map that identifies organ-specific metastasis patterns and molecular features, facilitating the identification of therapies and understanding metastatic behaviors.
Implementation Method 1
a detectable marker suitable for in vivo imaging
Data Source
AI summary
The invention features compositions and methods for determining the metastatic potential of cancer cell lines and tumors. Also provided is MetMap, a comprehensive database of the metastatic potential of cancer cell lines.